Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 1/20 | 0.48 |
| ▸ | ADH1C | P00326 | 1/20 | 0.48 |
| ▸ | ADH1A | P07327 | 1/20 | 0.48 |
| ▸ | ADH4 | P08319 | 1/20 | 0.48 |
| ▸ | ADH7 | P40394 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 5/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.38 |
| ▸ | GAPDH | P04406 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.38 |
| ▸ | FDPS | P14324 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10383718 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL14093766 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL93129 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL93171 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL2109688 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL2110531 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL8810975 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL2108219 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL14093584 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL10383121 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119403908-A | Method for enhancing psychological performance and composition for use in the method | 弗门尼舍有限公司 | 2025-02-07 | — | — | CN | claimed |
| US-9580636-B2 | Secondary esters, methods of making, and uses thereof | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2017-02-28 | — | — | US | claimed |
| US-20160319178-A1 | Secondary Esters, Methods of Making, and Uses Thereof | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2016-11-03 | — | — | US | claimed |
| WO-2016176243-A1 | SECONDARY ESTERS, METHODS OF MAKING, AND USES THEREOF | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2016-11-03 | — | — | WO | claimed |
| CN-119403908-A | Method for enhancing psychological performance and composition for use in the method | 弗门尼舍有限公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-109824871-B | Near-infrared two-zone fluorescent quinoid polymer, preparation method and application thereof | 南京邮电大学 | 2021-04-16 | — | — | CN | disclosed |
| CN-109824871-B | Near-infrared two-zone fluorescent quinoid polymer, preparation method and application thereof | 南京邮电大学 | 2021-04-16 | — | — | CN | disclosed |
| CN-106457273-B | Flush dispenser for delivering a consistent consumer experience | 宝洁公司 | 2019-05-07 | — | — | CN | disclosed |
| CN-106659280-A | Article providing long lasting fragrance | 宝洁公司 | 2017-05-10 | — | — | CN | disclosed |
| CN-106470661-A | Article providing long lasting fragrance | 宝洁公司 | 2017-03-01 | — | — | CN | disclosed |
| US-9580636-B2 | Secondary esters, methods of making, and uses thereof | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2017-02-28 | — | — | US | disclosed |
| US-9580636-B2 | Secondary esters, methods of making, and uses thereof | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2017-02-28 | — | — | US | disclosed |
| US-8716513-B2 | Process for production of bis-quaternary ammonium salt, and novel intermediate | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-05-06 | — | — | US | disclosed |
| EP-2463266-A1 | PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE | Wako Pure Chemical Industries, Ltd. (JP) | 2012-06-13 | — | — | EP | disclosed |
| US-20120130107-A1 | PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-05-24 | — | — | US | disclosed |
| US-8158375-B2 | Polymer and method of measuring cholesterol therewith | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-17 | — | — | US | disclosed |
| EP-2239281-A2 | Novel polymer and method for determining cholesterol using the same | Wako Pure Chemical Industries, Ltd. (JP) | 2010-10-13 | — | — | EP | disclosed |
| US-20090215097-A1 | Novel Polymer and Method of Measuring Cholesterol Therewith | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2009-08-27 | — | — | US | disclosed |
| EP-1903069-A1 | NOVEL POLYMER AND METHOD OF MEASURING CHOLESTEROL THEREWITH | Wako Pure Chemical Industries, Ltd. (JP) | 2008-03-26 | — | — | EP | disclosed |
| CN-1314906-A | Salts of paroxetine | SMITHKLINE BEECHAM PLC (GB) | 2001-09-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120130107-A1 | PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE | ASS1, C1S, FHIT | ADH1B 403/4885ADH1C 149/4885ADH1A 215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.